Shoffner J M, Brown M D, Torroni A, Lott M T, Cabell M F, Mirra S S, Beal M F, Yang C C, Gearing M, Salvo R
Department of Genetics, Emory University School of Medicine, Atlanta, Georgia 30322.
Genomics. 1993 Jul;17(1):171-84. doi: 10.1006/geno.1993.1299.
Mitochondrial DNA (mtDNA) variants associated with Alzheimer disease (AD) and Parkinson disease (PD) were sought by restriction endonuclease analysis in a cohort of 71 late-onset Caucasian patients. A tRNA(Gln) gene variant at nucleotide pair (np) 4336 that altered a moderately conserved nucleotide was present in 9/173 (5.2%) of the patients surveyed but in only 0.7% of the general Caucasian controls. One of these patients harbored an additional novel 12S rRNA 5-nucleotide insertion at np 956-965, while a second had a missense variant at np 3397 that converted a highly conserved methionine to a valine. This latter mutation was also found in an independent AD + PD patient, as was a heteroplasmic 16S rRNA variant at np 3196. Additional studies will be required to determine the significance, if any, of these mutations.
通过限制性内切酶分析,在71名晚发性白种人患者队列中寻找与阿尔茨海默病(AD)和帕金森病(PD)相关的线粒体DNA(mtDNA)变异。在所调查的患者中,9/173(5.2%)存在核苷酸对(np)4336处的tRNA(Gln)基因变异,该变异改变了一个中度保守的核苷酸,但在一般白种人对照中仅为0.7%。其中一名患者在np 956 - 965处有一个额外的新型12S rRNA 5核苷酸插入,而另一名患者在np 3397处有一个错义变异,将高度保守的甲硫氨酸转换为缬氨酸。在一名独立的AD + PD患者中也发现了后一种突变,在np 3196处的异质性16S rRNA变异也是如此。需要进一步的研究来确定这些突变的意义(如果有)。